December 5, 2023 01:22 PM ESTUpdated 05:45 PM

Scoop: Resonance Medicine, a protease biotech from David Liu’s lab, shuts down

Kyle LaHucik

Senior Reporter

Andrew Dunn

Senior Biopharma Correspondent

Resonance Medicine, a two-year-old stealth-stage biotech out of the lab of famed biochemist David Liu, has decided to shut down, Endpoints News has learned. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Scoop: Resonance Medicine, a protease biotech from David Liu’s lab, shuts down

Kyle LaHucik

Senior Reporter

Andrew Dunn

Senior Biopharma Correspondent

Sign up to read this article for free.

The Endpoints 2024 winners and losers list: Who was up and who was down in biopharma

CagriSema’s weight loss data disappointed. What does Novo do next?

CMS explains what went into its first round of drug price negotiations

Updated: Novo’s 23% weight loss with CagriSema falls short of high expectations, new trial planned

Deerfield wins fight to acquire Singular Genomics, beating out Tang Capital’s Concentra

Vertex gets 'vanza triple' approval and Trikafta expansion — with boxed warnings

Scoop: Res­o­nance Med­i­cine, a pro­tease biotech from David Liu’s lab, shuts down

Senior Reporter

Senior Biopharma Correspondent

Sign up to read this article for free.

more like this

Scoop: Resonance Medicine, a protease biotech from David Liu’s lab, shuts down